Antiviral activity of Tecovirimat against Mpox virus clades 1a, 1b, 2a and 2b
Jeanne PostaliD, Florence Guivel‐BenhassineiD, Françoise PorrotiD, Quentin Grassin, Jack M. CrookiD, Riccardo VernuccioiD, Valérie CaroiD, Jessica VanhomwegeniD, Pablo Guardado‐CalvoiD, Etienne Simon‐LorièreiD, Laurent DacheuxiD, Jean‐Claude ManuguerraiD, Olivier SchwartziD
Abstract
The recent Mpox virus (MPXV) outbreak was caused by a novel and more pathogenic clade 1b virus. We compared the antiviral efficacy of Tecovirimat in cell culture, against the two ancestral clades 1a and 2a, the clade 2b that circulated in 2022, and the recent clade 1b virus. We report that Tecovirimat similarly inhibits the replication of all four MPXV clades, at nanomolar concentrations (nM). Our results suggest that Tecovirimat remains a therapeutic option against the latest clade 1b virus.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 22
- FWCI
- 10.05
- Field percentile
- top 1%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The antiviral activity of licensed therapeutics against Mpox clade Ib, in vitro; alternative options for the treatment of Mpox
Amanda Horton, Helen Berryman, … Julia A. Tree·bioRxiv·Jan 11, 2025
- Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak
G. Frenois-Veyrat, F. Gallardo, … J.-N. Tournier·bioRxiv·Jul 19, 2022
- Drug screen reveals new potent host-targeted antivirals against Mpox virus
Arjit Vijey Jeyachandran, Anne K. Zaiss, … Vaithilingaraja Arumugaswami·bioRxiv·May 2, 2025
- Repurposing of the antibiotic nitroxoline for the treatment of mpox
D. Bojkova, N. Zoeller, … J. Cinatl·bioRxiv·Dec 29, 2022
- Potential anti-monkeypox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments
D. Akazawa, H. Ohashi, … K. Watashi·bioRxiv·Aug 2, 2022
- Antivirals against monkeypox infections
K. Chiem, A. Nogales, … L. Martinez-Sobrido·bioRxiv·Apr 19, 2023